Updates on androgen replacement therapy and lower urinary tract symptoms: a narrative review
Author | Al-Zoubi, Raed M. |
Author | Alwani, Mustafa |
Author | Aboumarzouk, Omar M. |
Author | Elaarag, Mai |
Author | Al-Qudimat, Ahmad R. |
Author | Ojha, Laxmi |
Author | Yassin, Aksam |
Available date | 2023-07-06T11:01:10Z |
Publication Date | 2022-09-06 |
Publication Name | Aging Male |
Identifier | http://dx.doi.org/10.1080/13685538.2022.2118253 |
Citation | Al-Zoubi, R. M., Alwani, M., Aboumarzouk, O. M., Elaarag, M., Al-Qudimat, A. R., Ojha, L., & Yassin, A. (2022). Updates on androgen replacement therapy and lower urinary tract symptoms: a narrative review. The Aging Male, 25(1), 234-241. |
ISSN | 1368-5538 |
Abstract | Lower urinary tract symptoms (LUTS) are caused by higher tension at the bladder neck level (due to fibrosis or stiffness) or benign prostatic hyperplasia, which causes static obstruction of the bladder outlet. Both forms cause a group of symptoms such as hesitancy, intermittency, weak stream, nocturia, urine frequency, and urgency. Additionally, LUTS (obstructive or irritative symptoms) are common in elderly men with hypogonadism, identified as the reduced testes capability in producing sex steroids and sperm, and are categorized as testosterone deficiency. Even though the mode of action (MoA) of testosterone therapy (TTh) on hypogonadal men needs more researched and understanding, the effectiveness of TTh in the development of male genital organs has been reported in several studies. This review shows the latest updates of TTh in LUTS including potential adverse effects, advantages, and disadvantages. |
Sponsor | Open Access funding provided by the Qatar National Library. |
Language | en |
Publisher | Taylor & Francis |
Subject | androgen BPH hypogonadism LUTS TRT |
Type | Article |
Pagination | 234-241 |
Issue Number | 1 |
Volume Number | 25 |
ESSN | 1473-0790 |
Files in this item
This item appears in the following Collection(s)
-
Biomedical Sciences [697 items ]